View details of this raise on Seedstage

Dover, DE

Integrating DNA-based precision medicine into routine healthcare visits.

• Innovative DNA Sequencing: Pioneering the use of DNA sequencing in each doctor’s visit to enhance diagnostic accuracy.
• Cost Advantage: Offers an 8-30x cost advantage for companies with self-insured healthcare plans.
• Patent-Pending Technology: Utilizes DNA Hyper-Sharding technology for secure and efficient genomic data storage.
• Rapid Diagnosis: Reduces the diagnostic process from years to minutes with AI-driven analysis.
• Economic Integration: Designed to fit seamlessly into existing healthcare systems, providing cost savings and improved patient outcomes.

DNA Chat Corporation is advancing the integration of precision medicine into routine healthcare through its Mendly Care platform. This virtual care system combines AI-driven symptom triage, comprehensive genome sequencing, and secure DNA storage to provide doctors with immediate access to a patient’s genetic data. The platform aims to replace traditional telemedicine with a DNA-first approach, enabling faster and more accurate diagnoses. Mendly Care addresses the inefficiencies in current medical practices, where patients often endure lengthy diagnostic processes and unnecessary tests. By offering a cost-effective solution for whole-genome sequencing, Mendly Care reduces the time and expense associated with diagnosing rare genetic conditions.

The company is leveraging its patented DNA Hyper-Sharding technology to ensure privacy and security in genomic data storage. This technology allows for real-time genetic analysis without compromising user privacy. Mendly Care’s business model is designed to integrate seamlessly into existing healthcare systems, offering significant cost savings for insurers and self-insured employers. The platform’s DNA-first approach not only accelerates diagnosis but also enhances patient safety by identifying genetic variants that could lead to adverse drug reactions. As Mendly Care expands, it plans to bring genome sequencing and telemedicine operations in-house, further increasing efficiency and control over quality.

Company Info

DNA Chat develops Mendly Care, a platform integrating AI and genomic data for precision medicine in routine healthcare visits.

DNA Chat focuses on integrating precision medicine into routine healthcare visits through its platform, Mendly Care. This virtual care system combines AI-driven symptom triage with full-genome sequencing and secure DNA storage, allowing doctors to access and interpret genetic data instantly and legally during patient consultations. Mendly aims to replace traditional telemedicine with a DNA-first approach, enhancing diagnostic accuracy and reducing healthcare costs by preventing misdiagnoses and adverse drug reactions.

The platform is designed to fit seamlessly into existing healthcare systems, offering significant cost savings for insurers and self-insured employers. Mendly’s patented DNA Hyper-Sharding technology ensures secure genomic data storage and rapid analysis, while its AI component streamlines the diagnostic process. By focusing initially on self-insured companies, Mendly plans to expand its reach through partnerships with health insurers, ultimately aiming to make DNA-informed care a standard practice in the healthcare industry.